Skip to main content
SpringerLink
Log in

Histidine decarboxylase inhibition: A novel approach towards the development of an effective and safe gastric anti-ulcer drug

  • Histamine and Kinins
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The involvement of histamine in mediating gastric function under normal and pathological conditions has been largely established. The relationship between gastric acid production and peptic ulcer diathesis is also well known. Recently, endogenous histamine formation and its release from mast cells has been implicated in the pathogenesis of human and experimental gastric ulcers produced by restraint and pyloric ligation. It has also been implicated in the gastric mucosal damage produced by drugs like aspirin, phenylbutazone and reserpine. These observations suggest that histidine decarboxylase inhibitors may be useful in the prevention of such lesions. Our studies on the evaluation of some histidine decarboxylase inhibitors show that these compounds have a promising potential for developing an effective and safe anti-ulcer drug. This mini-review incorporates the results of our studies which have been adequately supported by other studies as well.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. G. Kahlson, E. Rosengren, D. Svahn andR. Thunberg,Mobilization and formation of histamine in the gastric mucosa as related to gastric secretion, J. Physiol., Lond.174, 400–416 (1964).

    Google Scholar 

  2. P.A. Shore,Release of histamine from the stomach by vagus stimulating drugs: association with gastric acid secretion, Fedn Proc.24, 1322–1326 (1965).

    Google Scholar 

  3. R.J. Levine,Effect of histidine decarboxylase inhibition on gastric acid secretion in the rat, Fedn Proc.24, 1331–1333 (1965).

    Google Scholar 

  4. B.J. Haverback, M.I. Stubrin andB.J. Dyce,Relation of histamine to gastrin and other secretogogues. Fedn Proc.24, 1326–1330 (1965).

    Google Scholar 

  5. P.K. Rangachari,Histamine release by gastric stimulants. Nature, Lond.253, 53–55 (1975).

    Google Scholar 

  6. B.O. Amure andM. Ginsburg,Inhibitors of the histamine catabolism and the action of gastrin in the rat, Br. J. Pharmac.23, 476–485 (1976).

    Google Scholar 

  7. R.W. Schayer,Catabolism of physiological quantities of histamine in vivo, Physiol. Rev.39, 116–120 (1959).

    PubMed  Google Scholar 

  8. J.W. Black, W.A.M. Duncan, C.J. Durant, C.R. Ganellin andE.M. Parsons,Definition and antagonism of histamine H 2 receptors, Nature, Lond.236, 385–390 (1972).

    Google Scholar 

  9. J.I. Isenberg,A new look at peptic ulcer, Ann. intern. Med.84, 57–67 (1976).

    PubMed  Google Scholar 

  10. C.F. Code,Reflections on histamine gastric secretion and the H 2 receptor New Engl. J. Med.296, 1459–1462 (1977).

    PubMed  Google Scholar 

  11. D. Brodie, R. Marshal andO. Moreno,Effect of restraint on gastric acidity in the rat, Am. J. Physiol.202, 812–814 (1962).

    PubMed  Google Scholar 

  12. R.J. Levine andE.C. Senay,Studies on the role of acid in the pathogenesis of experimental stress ulcers, Psychosom. Med.32, 61–65 (1970).

    PubMed  Google Scholar 

  13. S. Dai andC.W. Ogle,Histamine H 2 receptor blockade: effect on methacholine induced gastric secretion in rats, IRCS med. Sc.3, 236–237 (1975).

    Google Scholar 

  14. P.H. Guth andP. Hall,Microcirculatory and mast cell'change in restraint induced gastric ulcers, Gastroenterology50, 562–570 (1966).

    PubMed  Google Scholar 

  15. R.J. Levine andE.C. Senay,Histamine in the pathogenesis of stress ulcer in the rat, Am. J. Physiol.214, 892–896 (1968).

    PubMed  Google Scholar 

  16. W. Lorenz andG. Feifel,Neue Gesichtspunkte zur Pathogenese des Streß- und Steroidulkus, Dt. med. Wschr.95, 1848–1850 (1970).

    Google Scholar 

  17. J.C. Schwartz, Y. Cohen andG. Valette,Histidine decarboxylase gastrique et ulceres experimentaux chez le rat, Biochem. Pharmac.15, 2122–2124 (1966).

    Article  Google Scholar 

  18. A.A.N. Abdel-Galil andP.B. Marshal,Phenylbutazone and histamine formation in rat glandular stomach: its relationship to gastric ulceration, Br. J. Pharmac.33, 1 (1968).

    Google Scholar 

  19. A. Kohut andA. Nicak,Effect of epinephrine, epinephrectomy and adrenodemedulation in phenylbutazone gastric ulceration in the young and adult rat. 4th International Congress of Pharmacology, Abstracts, 106 (1969).

  20. K.P. Bhargava, M.B. Gupta andK.K. Tangri,Mechanism of ulcerogenic activity of indomethacin and oxyphenbutazone, Eur. J. Pharmac.22, 191 (1973).

    Article  Google Scholar 

  21. M. Daas, M.B. Gupta andK.P. Bhargava,Biogenic amines in the pathogenesis of gastric ulceration induced by aspirin in rats, Indian J. med. Res.65, 273–278 (1977).

    PubMed  Google Scholar 

  22. C.W. Ogle andH.K. Lau,Disodium cromoglycate: a novel gastric anti-ulcer agent, Eur. J. Pharmac.65, 411–414 (1979).

    Article  Google Scholar 

  23. H.K. Lau andC.W. Ogle,A comparative study of the gastric ulcerogenic effects of stress and reserpine in rats with decreased stomach wall mast cell populations, Experientia36, 995–996 (1980).

    PubMed  Google Scholar 

  24. S. Dai, C.W. Ogle andC.H. Lo,The effects of metiamide on gastric secretion and stress ulceration in rats, Eur. J. Pharmac.33, 277–282 (1975).

    Article  Google Scholar 

  25. S. Okabe, K. Takeuchi, T. Murata andK. Takagi,Effects of cimetidine and atropine sulphate on gastric secretion and healing of gastric and duodenal ulcers in rats. Eur. J. Pharmac.41, 205–208 (1977).

    Article  Google Scholar 

  26. H.H. Lauterbach andP. Mattes,Effect of cimetidine, histamine H 2 receptor antagonist in the prevention of experimental stress ulcer in the rat, Eur. Surg. Res.10, 105–108 (1978).

    PubMed  Google Scholar 

  27. A.S. Macdonald, B.J. Steele andM.G. Bottomley,Treatment of stress induced upper gastro-intestinal haemorrhage with metiamide, Lancet1, 68–69 (1976).

    Article  PubMed  Google Scholar 

  28. R.E. Pounder, R.H. Hunt, M.A. Stekelman, G.J. Milton-Thompson andJ.J. Misiewicz,Healing of gastric ulcer during treatment with cimetidine, Lancet1, 327–328 (1976).

    Google Scholar 

  29. D.H. Winship,Cimetidine in the management of duodenal ulcers, Gastroenterology74, 402–406 (1978).

    PubMed  Google Scholar 

  30. J.P. Gee, L.K. Jim, A. Leibowitz andD.C. McLeod,A prospective review of cimetidine use, Drug Intell. Clin. Pharm.13, 567–571 (1979).

    Google Scholar 

  31. R.R. Schade andR.M. Donaldson,How physicians use cimetidine. A survey of hospitalized patients and published cases, New Engl. J. Med.304, 1281–1284 (1981).

    Google Scholar 

  32. S. Deflora,Cimetidine, ranitidine and their mutagenic nitroso derivatives, Lancet2, 993–994 (1981).

    Article  Google Scholar 

  33. R. Brimblecome,Cimetidine, nitrosation and carcinogenicity, Lancet2, 686–687 (1981).

    Article  Google Scholar 

  34. S. Deflora andA. Picciotto,Mutagenicity of cimetidine in nitrite enriched human gastric juice, Carcinogen.1, 925–930 (1981).

    Google Scholar 

  35. P.N. Magee, N.J. Mac Mortensen andW.K. Eltringham,Cimetidine, nitrosation and cancer, Lancet 984–992.

  36. W.P. Ritchie, Jr. J.J. Breen andD.I. Griggs,Prevention of stress ulcer by reducing gastric tissue histamine, Surgery62, 596–600 (1967).

    PubMed  Google Scholar 

  37. K.-F.R. Sewing andB. Binder, The effect of brocresine (NSD 1055) on diamine oxidase levels in the rat plasma, liver, stomach, and upper small intestinein vivo andin vitro. InHistamine p. 306 (Ed.Cz. Maslinski). Dowden, Hutchinson and Ross, Stroudsberg, Pennsylvania. 1973.

    Google Scholar 

  38. W. Lorenz, J. Kusche, H. Barth andCh. Mathias, Action of several flavonoids on enzyme of histidine metabolismin vitro. InHistamine, pp. 265–269 (Ed.Cz. Maslinski). Dowden, Hutchinson and Ross, Stroudsberg, Pennsylvania 1973.

    Google Scholar 

  39. W. Lorenz, H.-J. Reimann, J. Kusche, H. Barth, A. Schmal, A. Nusime, G. Schulte, R. Frolich, J. Schmidt andR. Raabe,Effects of (+)-catechin on several enzymes of histamine metabolism and on stress ulcer formation in the female rat, Naunyn-Schmiedeberg's Arch. Pharma. Suppl.287, 62 (1975).

    Google Scholar 

  40. T.F. Slater andM.N. Eakins, Interactions of (+)-cyanidanol-3 with free radical generating systems. InNew Trends in the Therapy of Liver Diseases, pp. 84 (Ed.H.A. Bertelli). Karger, Basel, 1975.

    Google Scholar 

  41. G. Hennings, Biochemical, pharmacological and toxicological evaluation of (+)-cyanidanol-3. InInternational Workshop on (+)-Cyanidanol-3 in Diseases of the Liver, pp. 6–9 (Ed.H.-O. Conn). The Royal Society of Medicine, Academic Press, London 1981.

    Google Scholar 

  42. P. Wendt, H.-J. Reimann, K. Swoboda, G. Hennings andG. Blumel,The use of flavonoids as inhibitors of histidine decarboxylase in gastric diseases, Experimental and clinical studies, Naunyn-Schmiedeberg's Arch. Pharma. Suppl.313, 238 (1980).

    Google Scholar 

  43. H.-J. Reimann, W. Lorenz, M. Fischer, R. Frolich, H.-J. Meyer andA. Schmal,Histamine and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress ulcer formation by (+)-catechin, an inhibitor of specific histidine decarboxylase in vitro, Agents and Actions7, 69–72 (1977).

    Google Scholar 

  44. N.S. Parmar,A pharmacological study on the effects of some bioflavonoids on experimentally induced inflammation, increased vascular permeability, gastric ulcers and galactosemic cataracts, Ph.D. Thesis, University of Madras, India (1977).

    Google Scholar 

  45. N.S. Parmar andM.N. Ghosh,Gastric anti-ulcer activity of (+)-cyanidanol-3, a histidine decarboxylase inhibitor. Eur. J. Pharmac.69, 25–32 (1981).

    Article  Google Scholar 

  46. N. Albertani-Borowski,3-Methoxy-5,7,3′4′-tetrahydroxyflavan, Drugs of the Future8, 209 (1983).

    Google Scholar 

  47. N.S. Parmar andM.N. Ghosh, Gastric anti-ulcer activity of 3-O-methyl-(+)catechin. InStudies in Organic Chemistry, Vol. 11, pp. 513–521 (EdsF. Farkas, M. Gabor, F. Kallay andH. Wagner). Elsevier, Amsterdam 1982.

    Google Scholar 

  48. N.S. Parmar andG. Hennings.The effect of 3-methoxy-5,7,3′4′-tetrahydroxyflavan on the restraint induced gastric ulceration augmented by aspirin, a gastric mucosal barrier breaker, Res. Comm. Chem. Path. & Pharmac.41, 337–340 (1983).

    Google Scholar 

  49. N.S. Parmar andG. Hennings,The gastric antisecretory activity of 3-methoxy-5,7,3′4′-tetrahydroxyflavan (ME) — a specific histidine decarboxylase inhibitor in rats, Agents and Actions, 1984, In press.

  50. A.M. Hackett andL.A. Griffiths,The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse and marmoset, Drug Metabolism & Excretion9, 54 (1981).

    Google Scholar 

  51. L.A. Griffiths,Topics in Flavonoid Chemistry and Biochemistry, p. 201 (EdsL. Farkas,M. Gabor andF. Kally) Elsevier, Amsterdam 1975.

    Google Scholar 

  52. N. Albinus, G. Frisch andG. Hennings,Histidine decarboxylase inhibition by O-methyl-3-(+)-catechin and gastric acid secretion in the cat, Agents and Actions13, 249–251 (1983).

    PubMed  Google Scholar 

  53. N.S. Parmar andG. Hennings,The gastric antiulcer activity of 3-methoxy-5,7,3′,4′-tetrahydroxyflavan a specific histidine decarboxylase (HDC) inhibitor. 43rd International Congress of Pharmaceutical Sciences, Montreux, 5–9 Sept. 1983. FIP Abstracts 171 (1983).

  54. D.P. Ganote, G. Hennings andP.W. Lucker, (+)-3-Methoxy-5,7,3′,4′-tetrahydroxyflavan (ME): a new compound to prevent gastric irritation. A gastric potential difference analysis, Meth. and Find. Exptl. Clin Pharmacol.5, 489–494 (1983).

    Google Scholar 

  55. H. Laule, P.W. Lucker, P. Altmayer andM.A. Eldon,Gastric potential difference as a model in clinical pharmacology: assessment of gastric mucosal response to aspirin, Eur. J. Clin. Pharmacol.22, 147–151 (1982).

    Article  PubMed  Google Scholar 

  56. J. Kollonitsch, A.A. Patchett, S. Marburg, A.L. Maycock, L.M. Perkins, G.A. Doldouras, D.E. Duggan andS.D. Aster,Selective inhibitors of biosynthesis of aminergic neurotransmitters, Nature274, 906–908 (1978).

    PubMed  Google Scholar 

  57. M. Garbarg, G. Barbin, E. Rodergas andJ.C. Schwartz,Inhibition of histamine synthesis in brain by fluoromethylhistidine, a new irreversible inhibitor, in vitro and in vivo studies, J. Neurochem.35, 1045–1048 (1980).

    PubMed  Google Scholar 

  58. B. Lippert, P. Bey, V. Dorsselaer, J.P. Vevert, C. Danzin, G. Ribereau-Gayon andM.J. Jung,Selective irreversible inhibition of mammalian histidine decarboxylase by chloromethylhistidine, Agents and Actions9, 38–39 (1979).

    PubMed  Google Scholar 

  59. M. Bouclier, M.J. Jung andF. Gerhart,Inhibition of histamine biosynthesis and gastric function in the rat: effect on pentagastrin induced gastric secretion, Agents and Actions13, 241–246 (1983).

    PubMed  Google Scholar 

  60. M. Mattsson, A. Henningsson, S. Henningsson, andL. Hammar,Effect of His-Phe, a competitive inhibitor of histidine decarboxylase, on gastric acid secretion in chronic gastric fistula rats. Delay in acid acid secretion response to pentagastrin, Agents and Actions12, 176–178 (1982).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, King Saud University, P.O. Box 2457, 11451, Riyadh, Saudi Arabia

    N. S. Parmar

  2. Zyma GmbH, D-8000, Munchen-70, West Germany

    G. Hennings

  3. Zyma SA, CH 1260, Nyon, Switzerland

    O. P. Gulati

Authors
  1. N. S. Parmar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Hennings
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. P. Gulati
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parmar, N.S., Hennings, G. & Gulati, O.P. Histidine decarboxylase inhibition: A novel approach towards the development of an effective and safe gastric anti-ulcer drug. Agents and Actions 15, 494–499 (1984). https://doi.org/10.1007/BF01966762

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966762

Keywords

Search

Navigation